-
October 4, 2016PREVIEW
Results of a cost-effectiveness analysis of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for patients with heterozygous familial hypercholesterolemia (FH) or atherosclerotic...
-
July 5, 2016PREVIEW
Use of statin therapy in intermediate-risk patients without cardiovascular (CV) disease resulted in significant reductions in the risk of major CV events, according to results of the Heart...
-
May 31, 2016PREVIEW
Use of evolocumab (Repatha—Amgen) resulted in greater reductions in LDL levels compared with ezetimibe (Zetia—Merck) and was well tolerated in patients with elevated LDL levels and a history of...
-
March 14, 2016PREVIEW
Major adverse cardiovascular events (MACE) and mortality were reduced with use of statins in patients with asymptomatic peripheral arterial disease (PAD) and no signs of cardiovascular disease in...
-
December 15, 2015PREVIEW
Use of lipid-lowering drugs, such as statins and fibrates, was associated with an approximately 30% decrease in the incidence of stroke in adults 65 years of age and older with no known history...
Pages
